RecallDepth
Class II Terminated

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA

This recall has been terminated (originally issued May 4, 2022).

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
April 15, 2022
Posted
May 4, 2022
Recall Number
D-0794-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
353964 units
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

cGMP Deviations

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: a) 16291, Exp. Date 01/2024;16469, Exp. Date 02/2024; b)16255, Exp. Date 11/2022; 16256, 16412 Exp. Date 02/2024; 16257, 16258, Exp. Date12/2022; 16505, 6506, Exp. Date 03/2024; 16627,16786, 16787,16820, Exp. Date 04/2024.

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls